Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Ibere Pharmaceuticals

    NYSE: IBER · Real-Time Price · USD
    10.18
    -0.02 (-0.20%)
    At close: Mar 01, 2023, 9:58 PM

    Ibere Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2021
    Period Ending Dec 31, 2021
    Revenue
    		 n/a
    Cost of Revenue
    		 n/a
    Gross Profit
    		 -1M
    Operating Income
    		 -1M
    Interest Income
    		 17.12K
    Pretax Income
    		 1.56M
    Net Income
    		 1.56M
    Selling & General & Admin
    		 n/a
    Research & Development
    		 n/a
    Other Expenses
    		 1M
    Operating Expenses
    		 n/a
    Interest Expense
    		 n/a
    Selling & Marketing Expenses
    		 n/a
    Cost & Expenses
    		 1M
    Income Tax Expense
    		 n/a
    Shares Outstanding (Basic)
    		 11.49M
    Shares Outstanding (Diluted)
    		 11.49M
    EPS (Basic)
    		 0.34
    EPS (Diluted)
    		 0.34
    EBITDA
    		 -3.55M
    EBIT
    		 -1M
    Depreciation & Amortization
    		 -2.55M

    Add to Watchlist